Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical efficacy, safety, and tolerability of
ViaDerm-shPTH [1-34] transdermal delivery in comparison to subcutaneous injection of
rhPTH[1-34] following 3-month treatment in postmenopausal women with Osteoporosis